{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:02:03Z","timestamp":1787313723802,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002349","name":"Academy of Scientific Research and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejmech.2020.112497","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T02:05:37Z","timestamp":1593050737000},"page":"112497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections"],"prefix":"10.1016","volume":"202","author":[{"given":"Inas G.","family":"Shahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader S.","family":"Abutaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Alhashimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa E.","family":"Kassab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled O.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza T.","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman S.","family":"Mayhoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112497_bib1","series-title":"Antibiotic\/antimicrobial Resistance. Biggest Threats and Data","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"10.1016\/j.ejmech.2020.112497_bib2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/joacp.JOACP_349_15","article-title":"Action and resistance mechanisms of antibiotics: a guide for clinicians","volume":"33","author":"Kapoor","year":"2017","journal-title":"J.\u00a0Anaesthesiol. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112497_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/0974-777X.157245","article-title":"Study of antibiotic resistance pattern in methicillin resistant Staphylococcus aureus with special reference to newer antibiotic","volume":"7","author":"Kaur","year":"2015","journal-title":"J.\u00a0Global Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112497_bib4","first-page":"207","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001"},{"key":"10.1016\/j.ejmech.2020.112497_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(18)30060-4","article-title":"WHO global antimicrobial resistance surveillance system early implementation 2016\u201317","volume":"18","author":"Tornimbene","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112497_bib6","first-page":"84","article-title":"Mechanisms of methicillin resistance in Staphylococcus aureus","author":"Peacock","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2020.112497_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijantimicag.2006.09.001","article-title":"Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control","volume":"28","author":"Gould","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2020.112497_bib8","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1172\/JCI38226","article-title":"Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era","volume":"119","author":"DeLeo","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2020.112497_bib9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1469-0691.2010.03365.x","article-title":"Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control","volume":"16","author":"Gould","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2020.112497_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2011.09.028","article-title":"New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance","volume":"39","author":"Gould","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2020.112497_bib11","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/jm401905m","article-title":"Discovery and characterization of potent thiazoles versus methicillin- and vancomycin-resistant Staphylococcus aureus","volume":"57","author":"Mohammad","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112497_bib12","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1021\/acs.jmedchem.6b00233","article-title":"Second-generation phenylthiazole antibiotics with enhanced pharmacokinetic properties","volume":"59","author":"Seleem","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2020.112497_bib13","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1021\/acsinfecdis.8b00172","article-title":"Naphthylthiazoles: targeting multidrug-resistant and intracellular Staphylococcus aureus with biofilm disruption activity","volume":"4","author":"Hagras","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112497_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ejmech.2017.08.039","article-title":"Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere with bacterial cell wall synthesis","volume":"139","author":"Eid","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112497_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmech.2017.02.044","article-title":"Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus","volume":"130","author":"Eissa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112497_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/14756366.2011.587418","article-title":"Design, synthesis and SAR exploration of hybrid 4-chlorophenylthiazolyl-s-triazine as potential antimicrobial agents","volume":"27","author":"Gahtori","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112497_bib17","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112497_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrmicro2182","article-title":"Staphylococcus epidermidis\u2014the\u2019accidental\u2019pathogen","volume":"7","author":"Otto","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112497_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.apjtb.2015.05.001","article-title":"Nosocomial infections and their control strategies","volume":"5","author":"Khan","year":"2015","journal-title":"Asian Pac. J. Trop. Biomed."},{"issue":"Suppl D","key":"10.1016\/j.ejmech.2020.112497_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jac\/31.suppl_D.177","article-title":"The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model","volume":"31","author":"Gudmundsson","year":"1993","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112497_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jac\/44.4.455","article-title":"Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in\u00a0vitro and in\u00a0vivo","volume":"44","author":"Totsuka","year":"1999","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112497_bib22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1046\/j.1365-2672.2002.01594.x","article-title":"The antibacterial activity of vancomycin towards Staphylococcus aureus under aerobic and anaerobic conditions","volume":"92","author":"Suller","year":"2002","journal-title":"J.\u00a0Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112497_bib23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/cmi.12527","article-title":"Intracellular replication of Staphylococcus aureus in mature phagolysosomes in macrophages precedes host cell death, and bacterial escape and dissemination","volume":"18","author":"Flannagan","year":"2016","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ejmech.2020.112497_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111593","article-title":"Phenylthiazoles with nitrogenous side chain: an approach to overcome molecular obesity","volume":"182","author":"Elsebaei","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112497_bib25","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0012-3692(15)33412-7","article-title":"Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia","volume":"124","author":"Wunderink","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ejmech.2020.112497_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111830","article-title":"Modifying the lipophilic part of phenylthiazole antibiotics to control their drug-likeness","volume":"185","author":"Hosny","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112497_bib27","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharm"},{"key":"10.1016\/j.ejmech.2020.112497_bib28","first-page":"103","article-title":"Green synthesis and characterization of some 4-substituted-N-aryl-1, 3-thiazole-2-amine derivative","volume":"2","author":"Mahajan","year":"2014","journal-title":"Asian J. Biochem. Pharmaceut. Res."},{"key":"10.1016\/j.ejmech.2020.112497_bib29","first-page":"765","article-title":"Synthesis, characterization and plant growth regulator activity of some substituted 2-amino benzothiazole derivatives","volume":"2","author":"Mahajan","year":"2013","journal-title":"J.\u00a0Appl. Chem."},{"key":"10.1016\/j.ejmech.2020.112497_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.18596\/jotcsa.375716","article-title":"Synthesis of thiazole derivatives as antimicrobial agents by green chemistry techniques","volume":"5","author":"Demirci","year":"2018","journal-title":"J.\u00a0Turk. Chem. Soc., Sect. A: Chemistry"},{"key":"10.1016\/j.ejmech.2020.112497_bib31","series-title":"Methods For Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. M7-A9. ninth ed., in, Wayne, PA","year":"2012"},{"key":"10.1016\/j.ejmech.2020.112497_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejmech.2018.03.044","article-title":"Phenylthiazoles with tert-Butyl side chain: metabolically stable with anti-biofilm activity","volume":"151","author":"Kotb","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112497_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ijantimicag.2018.02.003","article-title":"Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci","volume":"51","author":"Mohammad","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2020.112497_bib34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1099\/jmm.0.017905-0","article-title":"In\u00a0vitro postantibiotic effects of tomopenem (CS-023) against Staphylococcus aureus and Pseudomonas aeruginosa","volume":"59","author":"Tomozawa","year":"2010","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112497_bib35","doi-asserted-by":"crossref","first-page":"7998","DOI":"10.1021\/acs.jmedchem.9b00720","article-title":"From phenylthiazoles to phenylpyrazoles: broadening the antibacterial spectrum toward carbapenem-resistant bacteria","volume":"62","author":"Hammad","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112497_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2019.04.063","article-title":"Lipophilic efficient phenylthiazoles with potent undecaprenyl pyrophosphatase inhibitory activity","volume":"175","author":"Elsebaei","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112497_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/acsinfecdis.9b00211","article-title":"Balancing physicochemical properties of phenylthiazole compounds with antibacterial potency by modifying the lipophilic side chain","volume":"6","author":"Mancy","year":"2020","journal-title":"ACS Infect. Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420304694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420304694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:13:35Z","timestamp":1759328015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420304694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":37,"alternative-id":["S0223523420304694"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112497","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112497"}}